Curative Biotechnology, Inc. (CUBT)

OTCMKTS: CUBT · Delayed Price · USD

0.0269

+0.0069 (34.50%)

May 2, 2024, 3:59 PM EDT - Market closed

Curative Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	0.06	0.67	0.16	-	-
Cash & Cash Equivalents	0.06	0.67	0.16	-	-
Cash Growth	-91.25%	317.33%	-	-	-
Receivables	-	0.03	0.07	-	-
Other Current Assets	0.01	0.06	1.9	-	-
Total Current Assets	0.07	0.75	2.13	-	-
Goodwill	1.62	1.56	0.14	0.04	0.04
Other Long-Term Assets	0.4	0.1	0	-	-
Total Long-Term Assets	2.02	1.66	0.14	0.04	0.05
Total Assets	2.09	2.41	2.27	0.04	0.05
Current Debt	1.07	-	0.56	-	0.2
Other Current Liabilities	3.42	0.73	0.11	-	-
Total Current Liabilities	4.49	0.73	0.66	0.4	0.2
Other Long-Term Liabilities	18.13	18.04	6.13	-	-
Total Long-Term Liabilities	18.13	18.04	6.13	-	-
Total Liabilities	22.62	18.77	6.8	0.4	0.2
Total Debt	1.07	-	0.56	-	-
Common Stock	0.06	0.06	0	0.32	0.32
Retained Earnings	-32.61	-26.92	-8.1	-3.7	-4.03
Shareholders' Equity	-20.53	-16.36	-4.52	-0.36	-3.71
Net Cash / Debt	-1.01	0.67	-0.4	-	-
Net Cash Per Share	-0.00	0.20	-0.12	-	-
Working Capital	-4.42	0.02	1.47	-	-
Book Value Per Share	-0.04	-4.85	-1.33	-	-